The Phase-3 efficacy analysis of Covaxin will be made public by July, according to Bharat Biotech.
The company is also conducting phase-4 trials to see how successful the vaccine is in the real world. The comprehensive analysis of the phase-3 clinical trial results for Bharat Biotech's…